A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

NIAID Data Ecosystem2026-03-14 收录

晚期实体瘤TIL细胞疗法

免疫检查点抑制剂联合治疗

数据链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2751104 数据链接链接失效反馈

官方服务：

资源简介：

A multicenter trial to investigate TBio-4101, an autologous, neoantigen-selected, tumor-reactive TIL product, in patients with advanced solid malignancies.

创建时间：

2023-01-15

Supplementary Material for: Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy or tyrosine kinase inhibitors in advanced endometrial cancer: A systematic review and meta-analysis

晚期子宫内膜癌治疗

免疫检查点抑制剂联合治疗

Objective: The objective of this meta-analysis was to conduct a comprehensive assessment of the therapeutic effectiveness and safety profile of the combination of immune checkpoint inhibitors (ICIs) w

DataCite Commons2024-10-28 更新50

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

iPSC衍生NK细胞疗法

免疫检查点抑制剂联合治疗

FT500 is an off-the-shelf, iPSC-derived NK cell product that can bridge innate and adaptive immunity, and has the potential to overcome multiple mechanisms of immune checkpoint inhibitor (ICI) resista

NIAID Data Ecosystem20

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

肺癌免疫治疗

免疫检查点抑制剂联合治疗

Radiotherapy enhances systemic responses to anti-CTLA-4 antibodies in pre-clinical studies and in some melanoma patients, but its efficacy in inducing systemic responses against tumors unresponsive to

NIAID Data Ecosystem20

Microwave ablation combined with anti-PD-1/CTLA-4 therapy induces an antitumor immune response to renal cell carcinoma in a murine model

肾细胞癌免疫治疗

免疫检查点抑制剂联合治疗

The study was designed to evaluate the efficiency of microwave ablation (MWA) in combination with anti-programmed death receptor 1 (anti-PD-1)/cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) in r

Taylor & Francis Group2023-01-03 更新40

IPINIVO - A Pharmacodynamics study of Nivolumab in Combination with Ipilimumab in Patients with Advanced or Metastatic Solid Tumours’

肿瘤免疫治疗药效学

免疫检查点抑制剂联合治疗

Interventions: Approximately 21 eligible patients with advanced or metastatic solid tumors will be enrolled into two cohorts. In the first cohort, nine (9) subjects will receive 1mg/kg of ipilimumab

NIAID Data Ecosystem20

A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

资源简介：

相关数据集